Nitrosamine

• What it does mean is greater freedom, less restriction and a wider variety of food choices for 𝘩𝑒𝑎𝑙𝑡𝘩𝑦 individuals.
• According to scientists, beta glucans can reduce the absorption of dietary fats and promote cholesterol control all by itself, even in a diet containing moderate amounts of saturated fat and cholesterol.
• Scientists have reported that fiber helps to promote weight control by reducing the amount of calories the body absorbs .
• Scientists have also reported that antioxidants help to promote weight control by providing the body with the energy that it needs to burn fat more efficiently .

• This echoes research that has found the popularity of vaping among young people in the UK has surged in recent years.
• But vaping comes with many risks to young people, including harm to the lungs and brain.
• Young people who vape may be more likely to start smoking and find it harder to quit any nicotine use at all.
• And using vaping products alongside other products containing nicotine, like cigarettes, for example, may be even worse for their health.

Hidden risks

• There are many less obvious risks to vaping too.
• The chemicals in vape liquids – including various toxins, heavy metals and possibly even radioactive polonium – may be harmful.
• This could be because of the specific mix of ingredients different brands put in the vape liquid.
• Even if a vape liquid is advertised as being nicotine-free, it might still contain chemicals called nitrosamines, which are known to cause cancer.

Is a ban on disposable vapes enough?

• The forthcoming ban on disposable vapes in England, Scotland and Wales may not be enough to deal with the problem.
• With more than 400 vape brands already on the market, a more comprehensive approach is needed.

Amira Guirguis does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

• In February 2024, ARS Pharma announced the successful completion of the repeat dosing study of neffy in seasonal allergic rhinitis under nasal allergen challenge conditions.
• R&D Expenses: Research and development expenses were $3.4 million and $20.3 million for the quarter and year ended December 31, 2023, respectively.
• G&A Expenses: General and administrative expenses were $6.8 million and $47.3 million for the quarter and year ended December 31, 2023, respectively.
• Net Loss: Net loss was $7.2 million and $54.4 million for the quarter and year ended December 31, 2023, respectively.

• Eight Nitrosamine Implementation Oversight Group (NIOG) meeting
  EventHumanCorporate
  Date
  Location
  The Nitrosamine Implementation Oversight Group (NIOG) was set up by the European medicines regulatory network to oversee the harmonised implementation of the Article 5(3) CHMP opinion on nitrosamines in human medicinal products.
• The NIOG will be the main interface between regulators and industry to agree on topics requiring further scientific discussion.